Shanghai to ramp up support for cutting-edge biomedical tech

Lujiazui, the financial center in Shanghai, forms a perfect backdrop to the Bund area. [Wang Gang/For China Daily] Shanghai will strengthen efforts to develop cutting-edge biomedical technologies, such as gene and cell therapies, mRNA, synthetic biology and regenerative medicine, city government officials said in a news briefing on Tuesday. To further encourage innovation at the … Continue reading Shanghai to ramp up support for cutting-edge biomedical tech

Pharmanovia to boost investment in nation

With plenty of opportunities, China is expected to grow faster than other markets for United Kingdom-based global pharmaceutical company Pharmanovia, said a senior executive in an exclusive interview in Shanghai on Friday. Such continuous growth comes after China had already been the drugmaker’s No 1 market globally since 2023, accounting for roughly 25 percent of … Continue reading Pharmanovia to boost investment in nation

Beijing drug manufacturer aiming to develop liver fibrosis drug

An employee of Gyre Pharmaceuticals Co Ltd checks the production progress in a work shop at the company’s plant in Cangzhou, Hebei province, May 2024. [Photo provided to chinadaily.com.cn] Gyre Pharmaceuticals Co Ltd, also known as Beijing Continent, a Beijing-based innovative drug manufacturer for organ fibrosis, will deploy more resources to develop drugs related to … Continue reading Beijing drug manufacturer aiming to develop liver fibrosis drug

Sino Biopharm and Boehringer Ingelheim enter into strategic collaboration

Sino Biopharmaceutical Limited and Boehringer Ingelheim announce on Monday that they have entered into a strategic partnership. [Photo provided to chinadaily.com.cn] Sino Biopharmaceutical Limited, or Sino Biopharm, a China-based Hang Seng Index company, and Boehringer Ingelheim, a global biopharmaceutical company, announced on Monday that they had entered into a strategic partnership focusing on bringing innovative … Continue reading Sino Biopharm and Boehringer Ingelheim enter into strategic collaboration